Becton Dickinson reported third-quarter fiscal 2026 results with sales up 5.4%. Management guided for sales growth toward the higher end of its initial range and raised the midpoint of its adjusted diluted EPS guidance to $12.62-$12.72, up from $12.52-$12.72.
The pharmaceutical business is the star of BD's portfolio. We expect robust growth to continue, driven by demand for injectables such as GLP-1s.
BD's China segment is facing competitive bidding challenges, which continue to pressure overall growth in the country.
|
Metric
|
BDX
|
BAX
|
FPH
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.21 | 12.66 | 56.10 |
Price/Book Value | 2.06 | 2.15 | 12.45 |
Price/Sales | 2.61 | 1.16 | 11.48 |
Price/Cash Flow | 13.94 | 12.02 | 39.94 |
|
Metric
|
BDX
|
BAX
|
FPH
|
|---|---|---|---|
Quick Ratio | 0.36 | 1.12 | 1.59 |
Current Ratio | 0.94 | 1.95 | 2.31 |
Interest Coverage | 3.53 | −0.81 | 61.51 |
|
Metric
|
BDX
|
BAX
|
FPH
|
|---|---|---|---|
Return on Assets (Normalized) | 4.97% | 4.99% | 17.34% |
Return on Equity (Normalized) | 10.63% | 15.42% | 23.25% |
Return on Invested Capital (Normalized) | 7.26% | 7.44% | 21.70% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|J^hHmshm | LOCK|xYq | $130B | |||
| Alcon Inc
ALC
| LOCK|J>LD?ky | LOCK|>h^v | $34B | |||
| ResMed Inc
RMD
| LOCK|B?@H@xx# | LOCK|VCDp | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|fmGVt# | LOCK|^f&Qg | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|!>HvDJP | LOCK|V<& | $24B | |||
| Solventum Corp
SOLV
| LOCK|nVn&Sj | LOCK|Y! | $16B | |||
| The Cooper Companies Inc
COO
| LOCK|rk<t!RH | LOCK|d>Pw$ | $14B | |||
| Baxter International Inc
BAX
| LOCK|cD? | LOCK|V>G? | $13B | |||
| Align Technology Inc
ALGN
| LOCK|>c>@J< | LOCK|>D<# | $11B |
United States